Nurse Practitioner, Adult Health · Baltimore, MD
NPI
1124277249
Since 2008
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1830 E Monument St, Suite 418
Baltimore, MD, 21287
Phone (410) 614-1069
Groups this clinician bills Medicare through
Medicare paid, 2024
$9,392
143 services
Medicare patients, 2024
68
Average age 67
Drug cost, 2024
$3.6M
3,009 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Iryne Zziwa-Kabenge was code 99214 (office e&m - established), 29 times for 22 patients. In total Iryne Zziwa-Kabenge billed 143 services in 8 codes, and Medicare paid $9,392.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-08-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 29 | 22 | $74.74 | $2,167 |
| 99211 Office E&M - Established | Office | 16 | 16 | $9.83 | $157 |
| 99214 Office E&M - Established | Facility | 13 | 13 | $67.19 | $873 |
By year: 2022 $7,227 for 109 services; 2023 $11K for 187 services; 2024 $9,392 for 143 services.
Medicare prescription drug claims, 2024
In 2024, the drug Iryne Zziwa-Kabenge prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 387 prescriptions and refills. In total Iryne Zziwa-Kabenge wrote 3,009 Medicare prescriptions that cost $3.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 387 | 387 | 46 | $1.5M |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 173 | 175 | 21 | $646K |
| Atorvastatin Calcium Generic | 100 | 109 | 17 | $1,463 |
| Tivicay Dolutegravir Sodium | 97 | 97 | 13 | $241K |
| Enulose Lactulose | 95 | 95 | Under 11 | $2,588 |
| Warfarin Sodium Generic | 79 | 79 | Under 11 | $678 |
| Prezcobix Darunavir/Cobicistat | 78 | 78 | Under 11 | $192K |
| Amlodipine Besylate Generic | 76 | 77 | 14 | $663 |
| Farxiga Dapagliflozin Propanediol | 62 | 62 | Under 11 | $22K |
| Levothyroxine Sodium Generic | 61 | 61 | 12 | $937 |
| Furosemide Generic | 61 | 61 | 17 | $472 |
| Sertraline Hcl Generic | 58 | 58 | Under 11 | $468 |
| Valacyclovir Valacyclovir Hcl | 58 | 70 | 14 | $1,820 |
| Pregabalin Generic | 57 | 57 | Under 11 | $4,451 |
| Mirtazapine Generic | 53 | 53 | 15 | $1,512 |
Brand drugs: 1,304 claims; generic drugs: 1,684 claims; opioid claims: 87.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Iryne Zziwa-Kabenge were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.